BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27342697)

  • 21. 2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance.
    Chien SC; Chen PS; Huang YH; Tang SC; Li YH; Yeh HI
    J Formos Med Assoc; 2019 Oct; 118(10):1385-1392. PubMed ID: 30584005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin treatment, new-onset diabetes, and other adverse effects: a systematic review.
    Bang CN; Okin PM
    Curr Cardiol Rep; 2014 Mar; 16(3):461. PubMed ID: 24464306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin therapy and related risk of new-onset type 2 diabetes mellitus.
    Ruscica M; Macchi C; Morlotti B; Sirtori CR; Magni P
    Eur J Intern Med; 2014 Jun; 25(5):401-6. PubMed ID: 24685426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical aspects in the management of statin-associated muscle symptoms (SAMS).
    Laufs U; Filipiak KJ; Gouni-Berthold I; Catapano AL;
    Atheroscler Suppl; 2017 Apr; 26():45-55. PubMed ID: 28434484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lipid lowering therapy in geriatric patients].
    Lechleitner M
    Z Gerontol Geriatr; 2013 Aug; 46(6):577-85; quiz 586-7. PubMed ID: 23955359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin Intolerance From a Clinician's Perspective.
    Whayne TF
    Angiology; 2016 Mar; 67(3):205-7. PubMed ID: 26019266
    [No Abstract]   [Full Text] [Related]  

  • 27. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.
    Mach F; Ray KK; Wiklund O; Corsini A; Catapano AL; Bruckert E; De Backer G; Hegele RA; Hovingh GK; Jacobson TA; Krauss RM; Laufs U; Leiter LA; März W; Nordestgaard BG; Raal FJ; Roden M; Santos RD; Stein EA; Stroes ES; Thompson PD; Tokgözoglu L; Vladutiu GD; Gencer B; Stock JK; Ginsberg HN; Chapman MJ;
    Eur Heart J; 2018 Jul; 39(27):2526-2539. PubMed ID: 29718253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin myopathy: over-rated and under-treated?
    Maghsoodi N; Wierzbicki AS
    Curr Opin Cardiol; 2016 Jul; 31(4):417-25. PubMed ID: 27258372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying statin-associated autoimmune necrotizing myopathy.
    Albayda J; Christopher-Stine L
    Cleve Clin J Med; 2014 Dec; 81(12):736-41. PubMed ID: 25452351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Practical approach to statin intolerance].
    Štulc T; Beránková Š; Češka R
    Vnitr Lek; 2015 Nov; 61(11):936-41. PubMed ID: 26652780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes to the statin label: what they really mean.
    Harv Health Lett; 2012 May; 37(7):5. PubMed ID: 22737739
    [No Abstract]   [Full Text] [Related]  

  • 33. Statin Intolerance Clinical Guide 2018.
    Kajinami K; Tsukamoto K; Koba S; Inoue I; Yamakawa M; Suzuki S; Hamano T; Saito H; Saito Y; Masuda S; Nakayama T; Okamura T; Yamashita S; Kagawa T; Kaneyama J; Kuriyama A; Tanaka R; Hirata A;
    J Atheroscler Thromb; 2020 Apr; 27(4):375-396. PubMed ID: 31588101
    [No Abstract]   [Full Text] [Related]  

  • 34. Non-traditional dosing of statins in statin-intolerant patients-is it worth a try?
    Cornier MA; Eckel RH
    Curr Atheroscler Rep; 2015; 17(2):475. PubMed ID: 25432858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators.
    Whayne TF
    Angiology; 2011 Jul; 62(5):415-21. PubMed ID: 21421631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The controversies of statin therapy: weighing the evidence.
    Jukema JW; Cannon CP; de Craen AJ; Westendorp RG; Trompet S
    J Am Coll Cardiol; 2012 Sep; 60(10):875-81. PubMed ID: 22902202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune-mediated statin myopathy.
    Loganathan P; Oddis CV; Aggarwal R
    Expert Rev Clin Immunol; 2016; 12(1):33-8. PubMed ID: 26515829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study.
    Mansi IA; English J; Zhang S; Mortensen EM; Halm EA
    Drug Saf; 2016 Jun; 39(6):543-59. PubMed ID: 26979831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chinese Expert Consensus on the Clinical Diagnosis and Management of Statin Intolerance.
    Li JJ; Dou KF; Zhou ZG; Zhao D; Ye P; Chen H; Chen ZY; Peng DQ; Guo YL; Wu NQ; Qian J;
    Clin Pharmacol Ther; 2024 May; 115(5):954-964. PubMed ID: 38459425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiology patient page. Statin intolerance.
    Fitchett DH; Hegele RA; Verma S
    Circulation; 2015 Mar; 131(13):e389-91. PubMed ID: 25825402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.